NEWS ARCHIVE


Jupiter Presents Award-Winning Author

By | September 26, 2016

Jupiter LLS and Honors College Presents Author Edwidge Danticat

Worm Holds Key to Treating Epilepsy and Rapid Drug Discovery

By | September 26, 2016

Researchers from FAU, in collaboration with The Scripps Research Institute, have opened up the possibilities for rapid drug screens to treat seizures in the near future by using a microscopic nematode worm.

Max Planck-FAU Premier Doctoral Program

By | September 22, 2016

The nation's first International Max Planck Research School (IMPRS) for Brain and Behavior via FAU collaboration launched this fall semester with five students from FAU.

FAU Jupiter's LLS Announces Fall Schedule

By | August 1, 2016

秘密研究院 has announced the Lifelong Learning Society Jupiter course offerings for the fall semester, which begins Monday, Oct. 10.

New Dean of Harriet L. Wilkes Honors College

By | June 20, 2016

秘密研究院 has appointed Ellen S. Goldey, Ph.D., as the new dean of the Harriet L. Wilkes Honors College, effective Monday, Aug. 1.

FAU and Town of Jupiter Celebrate Arbor Day

By | May 11, 2016

秘密研究院 and Town of Jupiter officials recently celebrated Arbor Day and Honored Former Jupiter Mayor in the Robert J. Huckshorn Arboretum on FAU's John D. MacArthur Campus in Jupiter.

Renowned Neuroscientist to Lead FAU's New Brain Institute

By | May 10, 2016

Randy D. Blakely, Ph.D., a renowned neuroscientist and leading expert in synaptic pharmacology, neurotransmitter transporters, and neurogenetics, is at the helm of the newly-formed FAU Brain Institute.

First Graduate of FAU-Max Planck Degree Program

By | May 3, 2016

Brati Das, 32, recently became the first student approved to graduate with 秘密研究院's Integrative Biology and Neuroscience (IBAN) degree.

FAU Jupiter's LLS Awards $11,000 in Scholarships

By | April 25, 2016

FAU Jupiter's LLS awarded 11 scholarships to undergraduate and graduate students.

Researcher Receives NIH Grant for MS and Cancer Treatment

By | April 19, 2016

A leading scientist has received $540,250 from the NIH to continue his groundbreaking research to develop new therapeutic agents for collagen-based diseases including multiple sclerosis, cancer and sepsis.